Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
William F McIntyreAlexander P BenzJeffrey S HealeyStuart J ConnollyMu YangShun Fu LeeThalia Shoshana FieldMarco AlingsJuan Benezet-MazuecosGiuseppe BorianiJens Cosedis NielsenMichael R GoldFrancesco PergoliniTaya V GlotzerChristopher B GrangerRenato Deláscio LopesPublished in: Circulation (2024)
URL: https://www.clinicaltrials.gov; Unique identifier: NCT01938248.